EWTX Sale Disclosure
Donovan Joanne M. · SEC Form 4 · Filed Aug 14, 2026
Sale
Calculated transaction value
$126.7K
Donovan Joanne M. CMO
EWTX
Transaction date
Aug 13, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 1 day later
EWTX daily price context
Close on/before transaction
$43.18
Aug 13, 2026
Close before public filing
$43.18
Aug 13, 2026
Return since public filing
+2.87%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,919 shares @ $43.41
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001644087-26-000005
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$412.7K
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Edgewise Therapeutics, Inc. EWTX Current | Sale | Aug 13, 2026 | $126.7K |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Sale | Aug 12, 2026 | $35.61K |
| Edgewise Therapeutics, Inc. EWTX | Award | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Sale | Aug 12, 2026 | $124.3K |
| Edgewise Therapeutics, Inc. EWTX | Sale | Aug 12, 2026 | $121.46K |
| Edgewise Therapeutics, Inc. EWTX | Sale | Aug 12, 2026 | $4.62K |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Award | Aug 12, 2026 | $0 |